RP103-07: A Long-Term, Open-Label, Safety, Tolerability and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) In Patients with Cystinosis

Project: Research project

Project Details

StatusFinished
Effective start/end date9/18/12 → 10/4/13

Funding

  • Raptor Therapeutics, Inc. (RP103-07)